Entourage Health Provides Corporate Update
2023年12月5日 - 9:33PM
Entourage Health Corp. (
TSX-V:
ENTG) (
OTCQX: ETRGF)
(
FSE:4WE) ("
Entourage" or the
"
Company"), a Canadian producer and distributor of
award-winning cannabis products, today announced that Vincent Doré,
Entourage's Chief Legal Officer and Corporate Secretary, will step
down to pursue other career opportunities, effective December 18,
2023.
Mr. Doré joined Entourage Health in 2020 and has
played a vital role in overseeing all legal, compliance, and
regulatory matters, as well as shaping the corporate governance
landscape. His leadership contributed significantly to the
Company’s performance, guiding pivotal transactions that were
crucial in setting the strategic direction for future years.
“We appreciate Vincent’s many contributions
and service to Entourage Health as both Chief Legal Officer and
Corporate Secretary,” stated George Scorsis, CEO and Chair. “His
dedication and expertise made him a trusted advisor to the board
and leadership team. On behalf of Entourage, I would like to extend
best wishes for Vincent’s continued success in all his future
endeavours.”
About Entourage Health
Corp. Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp., a licence holder
producing and distributing cannabis products for both the medical
and adult-use markets. The Company owns and operates a fully
licensed 26,000 sq. ft. Aylmer, ON processing facility. With its
Starseed Medicinal medical-centric brand, Entourage has expanded
its multi-channelled distribution strategy. Starseed’s
industry-first, exclusive partnership with LiUNA, the largest
construction union in Canada, along with employers and union groups
complements Entourage’s direct sales to medical patients.
Entourage’s elite adult-use product portfolio includes Color
Cannabis, Saturday Cannabis – and now Dime Bag and Syndicate – sold
across eight provincial distribution agencies. Exclusive Canadian
producer and distributor of award-winning U.S.-based wellness brand
Mary’s Medicinals sold in both medical and adult-use channels.
Under a collaboration with the Boston Beer Company, Entourage is
also the exclusive distributor of cannabis-infused beverages
‘TeaPot’ in Canada. In addition, Entourage also entered into an
exclusive agreement with Irwin Naturals, a renowned nutraceutical
and herbal supplement formulator of popular branded wellness
products sold across North America.
Follow Entourage and its brands
on LinkedIn Instagram: Color
Cannabis, Saturday Cannabis, Starseed, Syndicate, Dime Bag
For Investor & Media
Enquiries:Catherine FlamanSenior Director, Communications
& Corporate
Affairs416-910-0279Catherine.flaman@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified using forward-looking
terminology such as "expect", "likely", "may", "will", "should",
"intend", "anticipate", "potential", "proposed", "estimate" and
other similar words, including negative and grammatical variations
thereof, or statements that certain events or conditions "may",
"would" or "will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions, and views of future events which management believes
to be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance, or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry in Canada generally; the
ability of Entourage to implement its business strategies;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities' regulatory authorities and
available on SEDAR+ at www.sedarplus.ca. The risk factors and other
factors noted in the disclosure documents could cause actual events
or results to differ materially from those described in any
forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
過去 株価チャート
から 10 2024 まで 11 2024
Entourage Health (TSXV:ENTG)
過去 株価チャート
から 11 2023 まで 11 2024